ASX Share rice
Tue 11 May 2021 - 05:49:pm (Sydney)

PTX Share Price

PRESCIENT THERAPEUTICS LIMITEDPTXPharmaceuticals, Biotechnology & Life Sciences

PTX Company Information


Prescient Therapeutics Limited





GIC Industry:


GIC Sub Industry:



100 Albert Road Melbourne VIC Australia 3205


61 3 9692 7222

MD, CEO & Director:

Mr. Yatomi-Clarke Steven Lee

CFO & Company Sec.:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

Chief Scientific Officer:

Prof. Said M. Sebti Ph.D., M.D.

Chief Medical Officer:

Dr. Terrence G. Chew

Head of Bus. Devel.:

Dr. James D. Winkler

Company Overview:

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of a range of cancers in Australia. The company's lead drug candidate is PTX-200, which is in Phase II clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. Prescient Therapeutics Limited has a collaboration agreement with Carina Biotech to develop cell therapies. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in South Melbourne, Australia.

PTX Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


PTX CashFlow Statement

CashFlow Date:


Change To Liabilities:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Capital Expenditures:


PTX Income Statement

Income Date:


Income Before Tax:


Net Income:


Operating Income:


Interest Expense:


Total Revenue:


PTX Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


PTX Share Price History

PTX News

25 Feb, 2021
We can readily understand why investors are attracted to unprofitable companies. For example, Prescient Therapeutics...
10 Nov, 2020
This article will reflect on the compensation paid to Yatomi-Clarke Lee who has served as CEO of Prescient...